Patient-Focused Research Symposium | November 18, 2026

https://vimeo.com/1248149234/28ae9008fe CLL experts share insights from their latest research — funded by CLL Global Research Foundation — and highlight how their work is directly improving outcomes for patients with chronic lymphocytic leukemia (CLL). Expert Panel: Dr. Christopher Oakes,  OSUCCC – James Dr. Elisa ten Hacken, Weill Medical College of Cornell University Dr. Alan Ramsay, King’s College […]

Promising New CLL Therapies and Clinical Trials

Dr. Jackie Broadway-Duren responds to an audience question about CLL clinical trials. Dr. Alessandra Ferrajoli explains that clinical trial options depend on where patients are in their treatment journey and emphasizes that trials offer close monitoring and an opportunity to improve existing therapies while bringing hope for better long-term outcomes.

MRD Explained | What It Means for Your CLL

Dr. Jackie Broadway-Duren responds to an audience question about minimal residual disease (MRD). Dr. Broadway-Duren defines MRD and goes on to share how this testing is used in CLL patient care.

CLL Survivorship Advances | Dr. Alessandra Ferrajoli

Dr. Alessandra Ferrajoli highlights her survivorship care research, including the importance of maintaining a healthy lifestyle through regular exercise, staying current with cancer screenings, and keeping up with vaccinations to support overall well-being.

Virtual Town Hall | Oct. 27, 2026

https://vimeo.com/1242490419?fl=pl&fe=sh During CLL Global Research Foundation’s October virtual town hall, CLL experts discussed ongoing research developments, updates in ongoing clinical trials, and answered audience questions. Download the program transcript. Download the slides. Expert Panel: Dr. Jackie Broadway, The University of Texas MD Anderson Cancer Center Dr. Alessandra Ferrajoli, The University of Texas MD Anderson Cancer […]

Defining the Evolution and Dynamics of CLL Transformation

https://vimeo.com/1211757566?share=copy&fl=sv&fe=ci During CLL Global Research Foundation’s Patient-Focused Research Symposium, Dr. Erin Parry discussed ongoing research into defining the evolution and dynamics of CLL transformation. Guest: Erin Parry, MD, PhD Dana-Farber Cancer Institute Transcript: Dr. Erin Parry: Thank you for the opportunity to be here today with you all, virtually. My name is Erin Parry, I’m […]

Whole Genome Doubling (Tetraploidy) in CLL and Richer’s Transformation

https://vimeo.com/1211757568?share=copy&fl=sv&fe=ci During CLL Global Research Foundation’s Patient-Focused Research Symposium, Dr. Jennifer Woyach discussed whole genome doubling in CLL and Richter’s transformation. Guest: Jennifer Woyach, MD The Ohio State University Comprehensive Cancer Center – The James Transcript: Dr. Jennifer Woyach: Hi, everybody. My name is Jennifer Woyach, from the Ohio State University, and I’m excited to […]

Progress in Resistant CLL and Richter Transformation

https://vimeo.com/1211758092?share=copy&fl=sv&fe=ci During CLL Global Research Foundation’s Patient-Focused Research Symposium, Dr. Constantine Tam discussed research progress in resistant CLL and Richter transformation. Guest: Prof Constantine Tam, M.B.B.S.(Hons) M.D. Alfred Health and Monash University Transcript: Prof Constantine Tam: Hi, my name is Con Tam. I am a hematologist in Melbourne, Australia, and a CLL researcher. And it […]

Targeting CLL With Cancer Vaccines

https://vimeo.com/1211757567 During CLL Global Research Foundation’s Patient-Focused Research Symposium, Dr. Catherine Wu explained ongoing research into targeting CLL with cancer vaccines. Guest: Catherine J. Wu, MD Dana-Farber Cancer Institute Transcript: Dr. Catherine J. Wu: Well, it’s a pleasure to be here, and to share with you some of our ongoing, exciting research. The title of […]